Aquestive Therapeutics elects Richard J. Daly to its Board as Class I director

Aquestive Therapeutics elected Richard J. Daly to its Board as a Class I director, effective October 14, 2026.Original SEC Filing: Aquestive Therapeutics, Inc. [ AQST ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the…